TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

INVENTIA

CardiovascularInfectious DiseaseGastroenterology
Generics

INVENTIA is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Gastroenterology. Key products include LANSOPRAZOLE.

2012
Since
11
Drugs
-
Trials
145
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PALIPERIDONE 2026-01-26
METFORMIN HYDROCHLORIDE 2025-11-10
Manufacturing (CMC)
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
OLMESARTAN MEDOXOMIL 2025-09-12
Labeling
OLMESARTAN MEDOXOMIL 2025-09-12
Labeling
PALIPERIDONE 2025-09-04
PALIPERIDONE 2025-09-03
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
3 drugs
Infectious Disease 33%
2 drugs
Gastroenterology 17%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease